---
figid: PMC5817860__12943_2018_796_Fig3_HTML
figlink: /pmc/articles/PMC5817860/figure/Fig3/
number: F3
caption: Crosstalk between c-Met and EGFR. a, b The tyrosine kinase receptors EGFR
  and c-Met can initiate downstream PI3K/Akt signaling resulting in anti-apoptotic
  processes and Grb2/MAPK activation to promote the proliferation of tumor cells.
  Therefore, it is speculated that there might be an effect that allows c-Met to bypass
  the EGFR receptor to activate its downstream pathway, resulting in resistance to
  EGFR-TKI monotherapy. c c-Met-TKI monotherapy triggers upregulation of the EGFR
  ligand TGF-α, as well as upregulation of the EGFR protein family receptor ErbB3,
  which can contribute to one of the most potent dimers that can activate c-Met downstream
  pathways leading to acquired resistance in cancer cells
pmcid: PMC5817860
papertitle: Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated
  therapeutic opportunities.
reftext: Yazhuo Zhang, et al. Mol Cancer. 2018;17:45.
pmc_ranked_result_index: '29597'
pathway_score: 0.9127276
filename: 12943_2018_796_Fig3_HTML.jpg
figtitle: Crosstalk between c-Met and EGFR
year: '2018'
organisms: Homo sapiens
ndex: 4d1d9843-df0f-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5817860__12943_2018_796_Fig3_HTML.html
  '@type': Dataset
  description: Crosstalk between c-Met and EGFR. a, b The tyrosine kinase receptors
    EGFR and c-Met can initiate downstream PI3K/Akt signaling resulting in anti-apoptotic
    processes and Grb2/MAPK activation to promote the proliferation of tumor cells.
    Therefore, it is speculated that there might be an effect that allows c-Met to
    bypass the EGFR receptor to activate its downstream pathway, resulting in resistance
    to EGFR-TKI monotherapy. c c-Met-TKI monotherapy triggers upregulation of the
    EGFR ligand TGF-α, as well as upregulation of the EGFR protein family receptor
    ErbB3, which can contribute to one of the most potent dimers that can activate
    c-Met downstream pathways leading to acquired resistance in cancer cells
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RASA1
  - SLC2A4RG
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - MTOR
  - PIK3R6
  - PIK3R5
  - MAPK3
  - SHC4
  - AKT2
  - MAPK1
  - PIK3R4
  - SOS2
  - BRAF
  - KRAS
  - ETV5
  - MAP2K1
  - MAPK12
  - SHC2
  - HRAS
  - NRAS
  - PIK3CG
  - TGFA
  - EGFR
  - MAPK13
  - MAP2K2
  - ARAF
  - EGF
  - MAPK14
  - GRB2
  - SOS1
  - SHC1
  - MAPK10
  - PIK3R3
  - RAF1
  - SLTM
  - AKT3
  - SHC3
  - MAPK11
  - AKT1
  - MAPK9
  - MAPK8
  - BAD
  - S-Met
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: GAP/GEF
  symbol: GAP
  source: hgnc_alias_symbol
  hgnc_symbol: RASA1
  entrez: '5921'
- word: GAP/GEF
  symbol: GEF
  source: hgnc_alias_symbol
  hgnc_symbol: SLC2A4RG
  entrez: '56731'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: ERK/M
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ERK/M
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: ERK/M
  symbol: ERM
  source: hgnc_alias_symbol
  hgnc_symbol: ETV5
  entrez: '2119'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: TGFa
  symbol: TGFA
  source: hgnc_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: C-Met
  symbol: Met
  source: hgnc_alias_symbol
  hgnc_symbol: SLTM
  entrez: '79811'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
chemicals:
- word: S-Met
  source: MESH
  identifier: C034758
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5817860__F3
redirect_from: /figures/PMC5817860__F3
figtype: Figure
---
